Cytokinetics Announces Upcoming Presentations at the HCMS Scientific Sessions and the HFSA Annual Scientific Meeting
Express News | Cytokinetics Announces Upcoming Presentations at the Hcms Scientific Sessions and the Hfsa Annual Scientific Meeting
S&P 500 Futures Up In Premarket Trading; Darden Restaurants, Mobileye Global Lead
Cytokinetics Insider Sold Shares Worth $414,401, According to a Recent SEC Filing
Health Check: How Prudently Does Cytokinetics (NASDAQ:CYTK) Use Debt?
B.Riley Financial Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $92
B.Riley Financial analyst Mayank Mamtani maintains $Cytokinetics(CYTK.US)$ with a buy rating, and maintains the target price at $92.According to TipRanks data, the analyst has a success rate of 26.8%